Abstract
The binding of lipoic acid (LA), to methylglyoxal (MG) modified BSA was studied using isothermal titration calorimetry in combination with enzyme kinetics and molecular modelling. The binding of LA to BSA was sequential with two sites, one with higher binding constant and another comparatively lower. In contrast the modified protein showed three sequential binding sites with a reduction in affinity at the high affinity binding site by a factor of 10. CD results show appreciable changes in conformation of the modified protein as a result of binding to LA. The inhibition of esterase like activity of BSA by LA revealed that it binds to site II in domain III of BSA. The pH dependence of esterase activity of native BSA indicated a catalytic group with a pKa = 7.9 ± 0.1, assigned to Tyr411 with the conjugate base stabilised by interaction with Arg410. Upon modification by MG, this pKa increased to 8.13. A complex obtained by docking of LA to BSA and BSA in which Arg410 is modified to hydroimidazolone showed that the long hydrocarbon chain of lipoic acid sits in a cavity different from the one observed for unmodified BSA. The molecular electrostatic potential showed that the modification of Arg410 reduced the positive electrostatic potential around the protein-binding site. Thus it can be concluded that the modification of BSA by MG resulted in altered ligand binding characteristics due to changes in the internal geometry and electrostatic potential at the binding site.
Similar content being viewed by others
Abbreviations
- AGES:
-
advanced glycation end products
- BSA:
-
bovine serum albumin
- CD:
-
circular dichroism spectroscopy
- GA:
-
genetic algorithm
- HSA:
-
human serum albumin
- ITC:
-
isothermal titration calorimetry
- LA:
-
lipoic acd
- MEP:
-
molecular electrostatic potential
- MG:
-
methylglyoxal
- NMR:
-
nuclear magnetic resonance
- PDB:
-
protein data bank
- UV:
-
ultraviolet
References
Ahmed N, Dobler D, Dean M, Thornalley PJ (2005) J Biol Chem 280:5724–5732
Baxter CA, Murray CW, Clark DE, Westhead DR, Eldridge MD (1998) Proteins 33:367–382
Bourdon E, Loreau N, Blache D. (1999) FASEB 13:233–244
Bradford MM (1976) Anal Biochem 72:248–254
Chen RF (1976) In Chen RF, Edelhoch H (eds) Biochemical fluorescence: concepts, Marcel Dekker, Inc, New York, pp 573–606
Eftink MR, Ghiron CA (1977). Biochemistry 16:5546–5551
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) J Comput-Aided Mol Des 11:425–445
Fan X, Subramaniam R, Weiss MF, Monnier VM (2003) Arch Biochem Biophys 409:274–286
Gao Y, Wang Y (2006) Biochemistry 45:15654–15660
Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S (2005) J Mol Biol 353:38–52
Gribskov M, Mclachlan AD, Eisenberg D (1987). Proc Natl Acad Sci USA 84:4355–4358
Gudiksen KL, Gitlin I, Yang J, Urbach AR (2005) J Am Chem Soc 127:4707–4714
Halgren T (1990) J Am Chem Soc 112:4710–4723
Kawabata T, Packer L (1994) Biochem Biophys Res Commun 203:99–104
Kellogg GE, Joshi GS, Abraham DJ (1992) Med Chem Res 1:444–453
Kumar SM, Mrudula T, Mitra N, Bhanuprakash Reddy G. (2004). Exp Eye Res 79:577–583
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) J Biol Chem 193:265–275
Luthy R, Bowie JU, Eisenberg D (1992) Nature 356:83–85
McLellan AC, Thornalley PJ, Benn J, Sonksen PH (1994) Clin Sci 87:21–29
Means GE, Bender ML (1975) Biochemistry 14:4989–4994
Murata-Kamiya N, Kamiya H (2001) Nucleic Acids Res 29:3433–3438
Nakajou K, Watanabe H, Kragh-Hansen U, Maruyama T, Otagiri M. (2003). Biochim Biophys Acta 1623:88–97
Otagiri M (2005) Drug Metab Pharmacokinet 20:309–323
Packer L, Witt EH, Tritschler HJ (1995) Free Radic Biol Med 19: 227–250
Ramasamy R, Yan SF, Schmidt AM (2006) Cell 124:258–260
Schepkin V, Kawabata T, Packer L (1994). Biochem Mol Biol Int 33:879–886
Thornalley PJ (1993) Mol Aspects Med 14:287–371
Thornalley PJ, Edwards LG, Kang Y, Wyatt C, Davies N, Ladan MJ, Double J (1996) Biochem Pharmacol 51:1365–1372
Watanabe H, Tanase S, Nakajou K, Maruyama T, Kragh-Hansen U, Otagiri M (2000) Biochem J 349:813–819
Westwood ME, Thornalley PJ (1995) J Protein Chem 14:359–372
Yang AS, Gunner MR, Sampogna R, Sharp K, Honig B (1993) Proteins 15:252–265
Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Ahmed N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M (2006) Cell 124:275–286
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.Figures for the molecular electrostatic potentials on the surface of BSA and modified BSA.
Rights and permissions
About this article
Cite this article
Suji, G., Khedkar, S.A., Singh, S.K. et al. Binding of Lipoic Acid Induces Conformational Change and Appearance of a New Binding Site in Methylglyoxal Modified Serum Albumin. Protein J 27, 205–214 (2008). https://doi.org/10.1007/s10930-008-9126-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-008-9126-3